… COVID-19-associated pulmonary aspergillosis (CAPA) is defined as invasive pulmonary
aspergillosis occurring in COVID… , biomarkers, and outcomes of hospitalized patients diagnosed …

… not associated with invasive pulmonary aspergillosis diagnosis in critically ill non-COVID-19
patients [28]. The risk of developing invasive pulmonary aspergillosis in COPD patients is …

… Pulmonary aspergillosis may complicate coronavirus disease 2019 (COVID-19) and … -19),
it is imperative to rule out coinfections that may contribute to poor outcomes. In patients …

… like influenza and coronavirus disease 2019 (COVID-19), the … COVID-19 is also an
independent risk factor for IPA and this entity is known as COVID-associated pulmonary aspergillosis …

… The outcome of COVID-19-associated pulmonary aspergillosis is poor and the recommend
antifungal agent – voriconazole should be used carefully in the concern of complicated drug–…

… molecular patterns during coronavirus disease-19 (COVID-19… of COVID-19-associated
pulmonary aspergillosis (CAPA) [1,2… in a significant number of critically ill COVID-19 patients [11]. …

… prone to secondary complications like invasive aspergillosis despite lack of underlying well-…
-pulmonary associated aspergillosis, we retrospectively analysed our patients with COVID-…

… invasive pulmonary aspergillosis in patients with COVID-… COVID-19 and invasive pulmonary
aspergillosis were recently described in France (33% of 27 admitted to the ICU with COVID…

… All observational cohort studies reporting the incidence and outcome of CAPA among
patients with COVID-19 admitted to the ICU were included in this meta-analysis. The exclusion …

… and mortality of COVID-19 associated pulmonary aspergillosis (… ventilated patients with
proven COVID-19 and acute respiratory … a minimal common outcome measure set for COVID-19 …